Mayo Clinic - RX for Weight Loss - A Closer Look

This four-part podcast series explores current recommendations for pharmacologic options in weight management and how to maintain a patient-centered approach. From identifying the right candidates for weight loss medications to coaching lifestyle changes and planning for long-term maintenance. Each episode offers practical insights for primary care professionals. We will also look ahead to the future of weight loss treatments and the impact of pharmacologic solutions. Whether you’re prescribing, consulting, or strategizing for sustained results for patients, this series equips you with the knowledge to guide patients to healthy outcomes.

Listening is free and no CME Credit is available for this series.  

Listen on your favorite podcast app below:

1. Listen to the podcast

Cancellation Policy

Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

CloudCME® reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 
CloudCME® is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Mitigation of Relevant Financial Relationships

CloudCME® adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.